Elevated Neutrophil-to-Lymphocyte Ratio Is Associated With Poor Outcomes for Melanoma Patients Treated With PD-1 Inhibitor or Chemotherapy in a Chinese Population

Elevated Neutrophil-to-Lymphocyte Ratio Is Associated With Poor Outcomes for Melanoma Patients Treated With PD-1 Inhibitor or Chemotherapy in a Chinese Population

Background: Previous studies have suggested that an elevated pre-treatment neutrophil-to-lymphocyte ratio (NLR) is associated with worse outcomes in patients with a variety of cancers. The purpose of this retrospective analysis is to investigate the prognostic value of the NLR in a Chinese melanoma...

Full description

Bibliographic Details
Main Authors: Yalong Qi, Daixiang Liao, Dinglian Mei, Yong Zhang, Yang Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-09-01
Series:Frontiers in Oncology
Subjects:
neutrophil-to-lymphocyte ratio
PD-1 inhibitor
melanoma
biomarker
prognosis
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.01752/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.01752/full

Similar Items